Monday, September 15, 2025 8:54:00 AM
Recent BIAF News
- bioAffinity Technologies Posts 2025 Results as CyPath Lung Testing Growth Accelerates • IH Market News • 03/13/2026 03:31:25 PM
- bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung • Business Wire • 03/13/2026 12:00:00 PM
- bioAffinity Launches Large-Scale Clinical Study for Lung Cancer Detection Technology • IH Market News • 03/10/2026 02:39:38 PM
- bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic • Business Wire • 03/10/2026 11:47:00 AM
- bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients • Business Wire • 03/03/2026 01:30:00 PM
- bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test • Business Wire • 02/25/2026 01:30:00 PM
- New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer • Business Wire • 02/19/2026 04:00:00 PM
- Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study • Business Wire • 02/17/2026 01:00:00 PM
- bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board • Business Wire • 02/09/2026 01:00:00 PM
- bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation • Business Wire • 01/07/2026 01:00:00 PM
- bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable • Business Wire • 12/03/2025 01:00:00 PM
- bioAffinity Technologies Reports Third Quarter 2025 Financial Results • Business Wire • 11/14/2025 01:00:00 PM
- bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume • Business Wire • 11/05/2025 01:00:00 PM
- bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases • Business Wire • 10/28/2025 12:00:00 PM
- bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025 • Business Wire • 10/20/2025 12:00:00 PM
- bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer • Business Wire • 10/16/2025 12:00:00 PM
- bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements • Business Wire • 10/15/2025 12:00:00 PM
- WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules • PR Newswire (US) • 10/09/2025 06:00:00 PM
- bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules • Business Wire • 10/09/2025 05:00:00 PM
- bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules • Business Wire • 10/08/2025 07:45:00 PM
- bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 • Business Wire • 10/07/2025 12:00:00 PM
- WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m • PR Newswire (US) • 09/30/2025 04:44:00 PM
- bioAffinity Technologies Announces Closing of $4.8 Million Public Offering • Business Wire • 09/30/2025 04:15:00 PM
- WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m • PR Newswire (US) • 09/29/2025 09:59:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
